🔎 Trials Near Me

Akèy › Kansè kol › Florid › Orlando

Etid klinik pou Kansè kol nan Orlando, FL

12 etid pou Kansè kol ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Ap rekriteFaz 2
  • AdventHealth Medical Group Oncology Research at Celebration, Kissimmee · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06172478

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

Ap rekriteEtid obsèvasyon
  • Orlando Health, Orlando
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05051722

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Ap rekriteFaz 4
  • AdventHealth, Orlando
  • AdventHealth Gynecologic Oncology, Orlando
  • AdventHealth Orlando Infusion Center, Orlando
  • ak 5 plis
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT06952660

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Ap rekriteFaz 1
  • Sara Cannon Research Institute Lake Nona, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Ap rekriteFaz 1/2
  • Florida Cancer Specialists - Lake Nona, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Ap rekriteFaz 1
  • Sarah Cannon Research Institute - Lake Nona Florida, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Ap rekriteFaz 1/2
  • AdventHealth Celebration, Celebration · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT05592626

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Ap rekriteFaz 1
  • Florida Cancer Specialists, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Ap rekriteFaz 1/2
  • Florida Cancer Specialists (from Sarah Canon research Institute), Orlando
Laj 18 ak plis · Tout sèks · Mizajou Feb 2, 2026 · NCT06319963

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Ap rekriteFaz 1
  • Dren Investigational Site, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Ap rekriteFaz 1/2
  • Research Site 137, Orlando
  • Research Site 118, Celebration · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05914116

A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib

Ap rekriteFaz 2
  • AdventHealth, Orlando
Laj 18 a 99 · Fanm · Mizajou Oct 22, 2025 · NCT05512208

Etid Kansè kol nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.